Copyright
        ©The Author(s) 2024.
    
    
        World J Gastroenterol. Feb 28, 2024; 30(8): 855-862
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.855
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.855
            Table 1 Baseline characteristics
        
    | Characteristics | Non-reflux esophagitis (n = 6296) | Reflux esophagitis (n = 1658) | P value | 
| Basic information | |||
| Age (yr), mean ± SD | 49.76 ± 8.00 | 50.81 ± 7.83 | < 0.001 | 
| Sex (male) [n (%)] | 4177 (66.34) | 1504 (90.71) | < 0.001 | 
| Systolic blood pressure (mmHg), mean ± SD | 123.40 ± 137.49 | 126.12 ± 16.78 | 0.421 | 
| Diastolic blood pressure (mmHg), mean ± SD | 80.58 ± 11.57 | 82.63 ± 11.06 | < 0.001 | 
| Drinking history [n (%)] | < 0.001 | ||
| No | 2567 (40.77) | 387 (23.34) | |
| Yes | 3592 (57.05) | 1231 (74.25) | |
| Abstain | 137 (2.17) | 40 (2.41) | |
| Smoking history [n (%)] | < 0.001 | ||
| No | 4073 (64.69) | 788 (47.53) | |
| Yes | 1777 (28.22) | 720 (43.43) | |
| Abstain | 446 (7.08) | 150 (9.05) | |
| Test results | |||
| White blood cell count (109/L), mean ± SD | 5.87 ± 1.44 | 6.21 ± 1.55 | < 0.001 | 
| Hemoglobin (g/L), mean ± SD | 143.31 ± 15.33 | 150.17 ± 12.61 | < 0.001 | 
| C-reactive protein (mg/L), mean ± SD | 0.16 ± 0.36 | 0.16 ± 0.31 | 0.999 | 
| Folic acid (ng/mL), mean ± SD | 9.50 ± 4.39 | 8.58 ± 4.05 | < 0.001 | 
| Homocysteine (μmol/L), mean ± SD | 12.35 ± 9.38 | 13.46 ± 6.96 | < 0.001 | 
| Brain natriuretic peptide precursor (pg/mL), mean ± SD | 34.59 ± 41.53 | 30.29 ± 49.06 | < 0.001 | 
| Total cholesterol (mmol/L), mean ± SD | 4.76 ± 0.90 | 4.72 ± 0.95 | 0.103 | 
| Fasting blood glucose (mmol/L), mean ± SD | 5.50 ± 1.17 | 5.68 ± 1.20 | < 0.001 | 
| Creatinine (μmol/L), mean ± SD | 67.92 ± 13.97 | 72.21 ± 12.79 | < 0.001 | 
| Total protein (g/L), mean ± SD | 70.14 ± 5.39 | 69.82 ± 5.25 | 0.031 | 
| 25-hydroxyvitamin D3 (ng/mL), mean ± SD | 19.79 ± 6.01 | 20.13 ± 6.14 | 0.040 | 
| Diseases [n (%)] | |||
| IgG-mediated food intolerance | 3781 (60.05) | 1132 (68.28) | < 0.001 | 
| Helicobacter pylori infection | 2478 (39.36) | 378 (22.80) | < 0.001 | 
| Metabolic syndrome | 3671 (58.31) | 1113 (67.13) | < 0.001 | 
            Table 2 Mediation effect analysis: Immunoglobulin G-mediated food intolerance
        
    | Indicators | Effect value | 95%CI | P value | 
| Total effect | -0.122064 | -0.138193, -0.104456 | < 0.0001 | 
| Average direct effect | -0.119349 | -0.135905, -0.102256 | < 0.0001 | 
| Average mediation effect | -0.002715 | -0.004145, -0.000316 | 0.0200 | 
| Average mediation effect percentage | 0.022242 | 0.002679, 0.034859 | 0.0200 | 
            Table 3 Mediation effect analysis: Metabolic syndrome
        
    | Indicators | Effect value | 95%CI | P value | 
| Total effect | -0.121571 | -0.138064, -0.104781 | < 0.0001 | 
| Average direct effect | -0.122715 | -0.139268, -0.105907 | < 0.0001 | 
| Average mediation effect | 0.001144 | 0.000182, 0.002307 | 0.0220 | 
| Average mediation effect percentage | -0.009413 | -0.018807, -0.001479 | 0.0220 | 
- Citation: Wang LH, Su BB, Wang SS, Sun GC, Lv KM, Li Y, Shi H, Chen QQ. Immunoglobulin G-mediated food intolerance and metabolic syndrome influence the occurrence of reflux esophagitis in Helicobacter pylori-infected patients. World J Gastroenterol 2024; 30(8): 855-862
- URL: https://www.wjgnet.com/1007-9327/full/v30/i8/855.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i8.855

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        